Uterine fibroids: estrogen, methylation and inflammation

Uterine fibroids are non-cancerous growths that develop within or on the muscular walls of the uterus. While conventional medicine often views them as a nuisance to be watched or surgically removed, they are actually highly sensitive hormone-responsive tissues. Think of a fibroid like a sponge that is specifically designed to soak up estrogen. When the body has an excess of growth-promoting hormones and a lack of inhibitory signals, these smooth muscle cells begin to multiply.

They can range in size from a tiny seed to a large grapefruit, and their location matters just as much as their size. Whether they are intramural, subserosal, or submucosal, they represent a systemic environment that is favoring cellular proliferation over cellular cleanup. In the black sheep view of health, a fibroid isn't a random glitch in your genetics; it is a physical manifestation of an internal terrain that has lost its regulatory balance.

Fibroids rarely stay quiet when they are growing. The most common signs include heavy menstrual bleeding, often involving large clots, and periods that seem to drag on for more than a week. Because these growths take up physical space, they often create a sensation of pelvic pressure or fullness that can feel like a dull, constant ache. Many women find themselves running to the bathroom every hour because a fibroid is physically pressing against the bladder.

These symptoms are more than just daily inconveniences; they are signals that the body is struggling to manage blood flow and inflammation. When you experience sharp pelvic pain or a protruding abdomen, your body isn't just failing you. It is signaling that the vascular and inflammatory pathways are overloaded. Instead of just managing the pain with pills or waiting for a surgery date, we look at these symptoms as data points showing how the environment inside the pelvis has shifted away from homeostasis.

The standard approach to fibroids is often "watch and wait." This essentially means waiting until the growths become large enough to justify surgery or a hysterectomy. This perspective mislabels fibroids as a localized "uterus problem" rather than a systemic metabolic and hormonal issue. By focusing only on the physical mass, conventional care misses the chemical signaling that caused the mass to grow in the first place.

Fibroids are often dismissed as an inevitable part of aging or a simple genetic destiny. However, this ignores the fact that the body is a connected ecosystem. Mislabeling them as a surgical-only issue prevents women from investigating why their body is producing so much excess tissue. When we stop viewing the uterus in isolation, we realize that a fibroid is often the end result of a much longer process involving how the body processes waste, manages stress, and regulates growth factors.

To understand why fibroids grow, we have to look at how the body handles estrogen. This involves the methylation-liver-gut axis. First, the liver must break down estrogen into safe metabolites. If the liver is sluggish or lacks the necessary nutrients for methylation, estrogen can be recycled back into the bloodstream in a more potent, aggressive form. This "estrogen dominance" acts like fertilizer for fibroid tissue.

The gut also plays a critical role through a collection of bacteria called the estrobolome. If the microbiome is imbalanced, an enzyme called beta-glucuronidase can unbind the estrogen your liver just worked to neutralize, allowing it to be reabsorbed. Furthermore, chronic systemic inflammation and insulin resistance can create a high-growth environment. When insulin levels are chronically elevated, it signals the body to build and store, which directly feeds the expansion of myomas.

We don't just look at an ultrasound and call it a day. To truly decode why fibroids are present, we must assess the hormonal pathways in detail. This means looking at how you are metabolizing estrogen—is it going down the protective pathway or the proliferative one? We investigate liver function and methylation markers to see if the body has the "shipping supplies" it needs to move hormones out of the building.

Assessment also includes looking at gut health and inflammatory markers to identify where the immune system might be getting tripped up. We analyze the nervous system's state, as chronic stress can shift the body into a state that favors survival over hormonal repair. By mapping out these biochemical intersections, we aim to understand the unique terrain of your body. The goal isn't just to acknowledge the fibroid, but to identify the specific drivers that are keeping the growth switch turned to the "on" position.